In 94% of calls, this medication was the only substance reported. Individuals report symptoms associated with known side effects of semaglutide, such as nausea, vomiting, and diarrhea
Applies to the following strengths: 4 mg
GLP-1, or glucagon-like peptide-1, enhances insulin secretion, inhibits glucagon release, and slows gastric emptying, leading to reduced appetite and increased satiety
5.3 Diabetic Retinopathy Complications In a 2-year trial involving patients with type 2 diabetes and high cardiovascular risk, more events of diabetic retinopathy complications occurred in patients treated with OZEMPIC (3.0%) compared to placebo (1.8%)
Can I switch from GLP-1 injections to drops